Prab: CSV import

2025-03-17T13:21:20Z

CSV import

← Older revision		Revision as of 13:21, 17 March 2025
Line 18:		Line 18:
	{{bacteria-stub}}		{{bacteria-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T17:55:59Z

CSV import

← Older revision		Revision as of 17:55, 10 February 2025
Line 17:		Line 17:
	[[Category:Gram-negative bacteria]]		[[Category:Gram-negative bacteria]]
	{{bacteria-stub}}		{{bacteria-stub}}
			{{No image}}

Prab: CSV import

2024-04-24T18:07:48Z

CSV import

New page

'''Fusobacterium polymorphum''' is a species of bacteria within the genus [[Fusobacterium]], which is part of the family [[Fusobacteriaceae]]. This genus is known for its significance in various human and animal diseases, particularly those associated with periodontal diseases, Lemierre's syndrome, and other infections. ''Fusobacterium polymorphum'', like other members of its genus, is anaerobic, meaning it does not require oxygen for growth, and is often found in the oral cavity, as well as in the gastrointestinal and genitourinary tracts.

==Characteristics==
''Fusobacterium polymorphum'' is characterized by its polymorphic nature, as its name suggests, appearing in various shapes from long filaments to more coccobacillary forms. This bacterium is Gram-negative, which means it does not retain the crystal violet stain used in the Gram staining method of bacterial differentiation. The presence of ''Fusobacterium polymorphum'' in clinical samples can indicate an infection, especially in contexts where anaerobic bacteria are known to be pathogenic.

==Pathogenicity==
The pathogenic potential of ''Fusobacterium polymorphum'' is linked to its ability to produce a variety of virulence factors, including but not limited to, lipopolysaccharides, leukotoxins, and hemagglutinins. These factors can contribute to the bacterium's ability to invade host tissues, evade the immune response, and establish infections. Infections by ''Fusobacterium'' species can range from periodontal diseases to more severe, life-threatening conditions such as bacteremia and sepsis, particularly in immunocompromised individuals.

==Clinical Significance==
In the clinical setting, the identification of ''Fusobacterium polymorphum'' is important for diagnosing and managing infections caused by this bacterium. Its presence in clinical specimens, such as from the oral cavity or blood, necessitates careful consideration of anaerobic coverage in antimicrobial therapy. The treatment of infections caused by ''Fusobacterium polymorphum'' typically involves the use of antibiotics effective against anaerobic bacteria, such as metronidazole or clindamycin.

==Research and Future Directions==
Research on ''Fusobacterium polymorphum'' and its role in human health and disease is ongoing. Studies are focused on understanding the mechanisms of pathogenicity, the interactions between this bacterium and the host immune system, and the development of effective treatments and preventive measures. As with other Fusobacterium species, there is interest in exploring the potential associations between ''Fusobacterium polymorphum'' and systemic diseases, including colorectal cancer and other inflammatory conditions.

[[Category:Bacteria]]
[[Category:Anaerobic bacteria]]
[[Category:Gram-negative bacteria]]
{{bacteria-stub}}

Fusobacterium polymorphum - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import